Amyloid precursor protein (APP) and the biology of proteolytic processing: Relevance to Alzheimer's disease

International Journal of Biochemistry and Cell Biology

Volumn 35, Issue 11, 2003, Pages 1505-1535

  Ling, Yan ^a   Morgan, Kevin ^a   Kalsheker, Noor ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Proteolytic processing

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 2 MACROGLOBULIN; ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; BETA SECRETASE; BETA SECRETASE INHIBITOR; GAMMA SECRETASE; INSULINASE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MEMBRANE METALLOENDOPEPTIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; PLASMIN; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; CLINICAL TRIAL; ENZYME ACTIVITY; ENZYME POLYMORPHISM; GENE CONTROL; HUMAN; IMMUNIZATION; NERVE DEGENERATION; NONHUMAN; OLIGOMERIZATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW;

LEUCISCUS IDUS;

EID: 0038343343     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(03)00133-X     Document Type: Review

References (308)

1. Abraham C.R., Myers A., Wavrant-DeVrieze F., Hamshere M.L., Thomas H.V., Marshall H., Compton D., Spurlock G., Turic D., Hoogendoorn B., Kwon J.M., Petersen R.C., Tangalos E., Norton J., Morris J.C., Bullock R., Liolitsa D., Lovestone S., Hardy J., Goate A., O'Donovan M., Williams J., Owen M.J., Jones L. Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Human Genetics. 109:2001;646-652.
2. Abraham C.R., Selkoe D.J., Potter H. Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell. 52:1988;487-501.
3. Acquati F., Accarino M., Nucci C., Fumagalli P., Jovine L., Ottolenghi S., Taramelli R. The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region. FEBS Letters. 468:2000;59-64.
4. Affholter J.A., Fried V.A., Roth R.A. Human insulin-degrading enzyme shares structural and functional homologies with E. coli protease III. Science. 242:1998;1415-1418.
5. Affholter J.A., Hsieh C.-L., Francke U., Roth R.A. Insulin-degrading enzyme: Stable expression of the human complementary DNA, characterization of its protein product, and chromosomal mapping of the human and mouse genes. Molecular Endocrinology. 4:1999;1125-1135.
6. Alonso D.F., Farias E.F., Famulari A.L., Dominguez R.O., Kohan S., de Lustig E.S. Excessive urokinase-type plasminogen activator activity in the euglobulin fraction of patients with Alzheimer-type dementia. Journal of Neurological Sciences. 139:1996;83-88.
7. Annaert W.G., Levesque L., Craessaerts K., Dierinck I., Snellings G., Westaway D., St. George-Hyslop P.H., Cordell B., Fraser P., De Strooper B. Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons. The Journal of Cell Biology. 147:1999;277-294.
8. Baki L., Marambaud P., Efthimiopoulos S., Georgakopoulos A., Wen P., Cui W., Shioi J., Koo E., Ozawa M., Friedrich V.L. Jr., Robakis N.K. Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex. Proceedings of the National Academy of Sciences of the United States of America. 98:2001;2381-2386.
9. 1-antitrypsin genes. Biochemistry. 26:1987;7755-7759.
10. Bard F., Cannon C., Barbour R., Burke R.L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Lieberburg I., Motter R., Nguyen M., Soriano F., Vasquez N., Weiss K., Welch B., Seubert P., Schenk D., Yednock T. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nature Medicine. 6:2000;916-919.
11. Barker P.E., Shipp M.A., D'Adamio L., Masteller E.L., Reinherz E.L. The common acute lymphoblastic leukemia antigen gene maps to chromosomal region 3 (q21-q27). Journal of Immunology. 142:1989;283-287.
12. Baum L., Chen L., Ng H.K., Pang C.P. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology. Microscopy Research and Technique. 50:2000;278-281.
13. Beisiegel U., Weber W., Ihrke G., Herz J., Stanley K.K. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature. 341:1989;162-164.
14. Benjannet S., Elagoz A., Wickham L., Mamarbachi M., Munzer J.S., Basak A., Lazure C., Cromlish J.A., Sisodia S., Checler F., Chretien M., Seidah N.G. Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production. The Journal of Biological Chemistry. 276:2001;10879-10887.
15. Bennett B.D., Denis P., Haniu M., Teplow D.B., Kahn S., Louis J.C., Citron M., Vassar R. A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's beta-secretase. The Journal of Biological Chemistry. 275:2000;37712-37717.
16. Bergqvist D., Nilsson I.M. Hereditary 2-macroglobulin deficiency. Scandinavian Journal of Haematology. 23:1979;433-436.
17. 1-antichymotrypsin. Journal of Medicine. 16:1985;101-128.
18. Bernstein H.G., Ansorge S., Riederer P., Reiser M., Frolich L., Bogerts B. Insulin-degrading enzyme in the Alzheimer's disease brain: Prominent localization in neurons and senile plaques. Neuroscience Letters. 263:1999;161-164.
19. Bertram L., Blacker D., Mullin K., Keeney D., Jones J., Basu S., Yhu S., McInnis M.G., Go R.C., Vekrellis K., Selkoe D.J., Saunders A.J., Tanzi R.E. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science. 290:2000;2302-2303.
20. Binder R.J., Han D.K., Srivastava P.K. CD91: A receptor for heat shock protein gp96. Nature Immunity. 1:2000;151-155.
21. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S., Nelson N., Boiani N., Schooley K.A., Gerhart M., Davis R., Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., Cerretti D.P. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 385:1997;729-733.
22. Blacker D., Wilcox M.A., Laird N.M., Rodes L., Horvath S.M., Go R.C., Perry R., Watson B. Jr., Bassett S.S., McInnis M.G., Albert M.S., Hyman B.T., Tanzi R.E. α2-Macroglobulin is genetically associated with Alzheimer disease. Nature Genetics. 19:1998;357-360.
23. Blanquet V., Goldgaber D., Turleau C., Creau-Goldberg N., Delabar J., Sinet P.M., Roudier M., de Grouchy J. In situ hybridization of the beta amyloid protein (APP) cDNA to the vicinity of the interface of 21q21 and q22 in normal and Alzheimer's disease individuals. Cytogenetics and Cell Genetics. 46:1987;582.
24. Blobel C.P. Metalloprotease-disintegrins: Links to cell adhesion and cleavage of TNF alpha and Notch. Cell. 90:1997;589-592.
25. Bodendorf U., Danner S., Fischer F., Stefani M., Sturchler-Pierrat C., Wiederhold K.H., Staufenbiel M., Paganetti P. Expression of human beta-secretase in the mouse brain increases the steady-state level of beta-amyloid. Journal of Neurochemistry. 80:2002;799-806.
26. Bodendorf U., Fischer F., Bodian D., Multhaup G., Paganetti P. A splice variant of beta secretase deficient in the amyloidogenic processing of the amyloid precursor protein. The Journal of Biological Chemistry. 276:2001;12019-12023.
27. Borth W. Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics. The FASEB Journal. 6:1992;3345-3353.
28. Bunn P.A. Jr., Helfrich B.A., Brenner D.G., Chan D.C., Dykes D.J., Cohen A.J., Miller Y.E. Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo. Clinical Cancer Research. 2:1998;2849-2858.
29. Buxbaum J.D., Koo E.H., Greengard P. Protein phosphorylation inhibits production of Alzheimer amyloid beta/A4 peptide. Proceedings of the National Academy of Sciences of the United States of America. 90:1993;9195-9201.
30. Buxbaum J.D., Liu K.N., Luo Y., Slack J.L., Stocking K.L., Peschon J.J., Johnson R.S., Castner B.J., Cerretti D.P., Black R.A. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. The Journal of Biological Chemistry. 272:1998;27765-27767.
31. Cai H., Wang Y., McCarthy D., Wen H., Borchelt D.R., Price D.L., Wong P.C. BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nature Neuroscience. 4:2001;233-234.
32. Cao X., Sudhof T.C. A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60. Science. 293:2001;115-120.
33. Capell A., Grunberg J., Pesold B., Diehlmann A., Citron M., Nixon R., Beyreuther K., Selkoe D.J., Haass C. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex. The Journal of Biological Chemistry. 273:1998;3205-3211.
34. Capell A., Steiner H., Willem M., Kaiser H., Meyer C., Walter J., Lammich S., Multhaup G., Haass C. Maturation and pro-peptide cleavage of beta-secretase. The Journal of Biological Chemistry. 275:2000;30849-30854.
35. Carson J.A., Turner A.J. Beta-amyloid catabolism: Roles for neprilysin (NEP) and other metallopeptidases? Journal of Neurochemistry. 81:2002;1-8.
36. Cataldo A.M., Nixon R.A. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proceedings of the National Academy of Sciences of the United States of America. 87:1990;3861-3865.
37. 1-antitrypsin, and antithrombin III. Biochemistry. 22:1983;5055-5061.
38. Chantry A., Gregson N.A., Glynn P. A novel metalloproteinase associated with brain myelin membranes. Isolation and characterization. The Journal of Biological Chemistry. 264:1989;21603-21607.
39. Charlwood J., Dingwall C., Matico R., Hussain I., Johanson K., Moore S., Powell D.J., Skehel J.M., Ratcliffe S., Clarke B., Trill J., Sweitzer S., Camilleri P. Characterization of the glycosylation profiles of Alzheimer's beta-secretase protein Asp-2 expressed in a variety of cell lines. The Journal of Biological Chemistry. 276:2001;16739-16748.
40. Chen F., Yu G., Arawaka S., Nishimura M., Kawarai T., Yu H., Tandon A., Supala A., Song Y.Q., Rogaeva E., Milman P., Sato C., Yu C., Janus C., Lee J., Song L., Zhang L., Fraser P.E., St. George-Hyslop P.H. Nicastrin binds to membrane-tethered Notch. Nature Cell Biology. 3:2001;751-754.
41. Chung H., Brazil M.I., Soe T.T., Maxfield F.R. Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells. The Journal of Biological Chemistry. 274:1999;32301-32308.
42. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St. George-Hyslop P.H., Selkoe D.J. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nature Medicine. 3:1997;67-72.
43. Cohen A.J., Miller Y.E. Neuroendocrine differentiation, neuropeptides, and neprilysin. American Journal of Respiratory Cell and Molecular Biology. 21:1999;1-3.
44. Colciaghi F., Borroni B., Pastorino L., Marcello E., Zimmermann M., Cattabeni F., Padovani A., Di Luca M. α-Secretase ADAM10 as well as αAPPs is reduced in platelets and CSF of Alzheimer disease patients. Molecular Medicine. 8:2002;67-74.
45. Cook D.G., Sung J.C., Golde T.E., Felsenstein K.M., Wojczyk B.S., Tanzi R.E., Trojanowski J.Q., Lee V.M., Doms R.W. Expression and analysis of presenilin 1 in a human neuronal system: Localization in cell bodies and dendrites. Proceedings of the National Academy of Sciences of the United States of America. 93:1996;9223-9228.
46. Corder E.H., Basun H., Lilius L., Corder L.S., Viitanen M., Winbalnd B., Lannfelt L. Alzheimer's risk in relation to α1-antichymotrypsinand apolipoprotein E polymorphism in very old adults age 75+. Alzheimer Research. 2:1996;51-54.
47. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
48. Creemers J.W., Ines Dominguez D., Plets E., Serneels L., Taylor N.A., Multhaup G., Craessaerts K., Annaert W., De Strooper B. Processing of beta-secretase by furin and other members of the proprotein convertase family. The Journal of Biological Chemistry. 276:2001;4211-4217.
49. D'Adamio L., Shipp M.A., Masteller E.L., Reinherz E.L. Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): Multiple miniexons and separate 5′ untranslated regions. Proceedings of the National Academy of Sciences of the United States of America. 86:1989;7103-7107.
50. Dahlgren K.N., Manelli A.M., Stine W.B. Jr., Baker L.K., Krafft G.A., LaDu M.J. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. The Journal of Biological Chemistry. 277:2002;32046-32053.
51. DeMattos R.B., Bales K.R., Cummins D.J., Dodart J.C., Paul S.M., Holtzman D.M. Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases A beta burden in a mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 98:2001;8850-8855.
52. De Strooper B., Annaert W., Cupers P., Saftig P., Craessaerts K., Mumm J.S., Schroeter E.H., Schrijvers V., Wolfe M.S., Ray W.J., Goate A., Kopan R. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature. 398:1999;518-522.
53. De Strooper B., Beullens M., Contreras B., Levesque L., Craessaerts K., Cordell B., Moechars D., Bollen M., Fraser P., St. George-Hyslop P.H., van Leuven F. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. The Journal of Biological Chemistry. 272:1997;3590-3598.
54. Deng G., Pike C.J., Cotman C.W. Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cells. FEBS Letters. 397:1996;50-54.
55. Devriendt K., Zhang J., van Leuven F., van den Berghe H., Cassiman J.J., Marynen P. A cluster of alpha 2-macroglobulin-related genes (alpha 2 M) on human chromosome 12p: Cloning of the pregnancy-zone protein gene and an alpha 2M pseudogene. Gene. 81:1989;325-334.
56. Dewji N.N., Singer S.J. Cell surface expression of the Alzheimer disease-related presenilin proteins. Proceedings of the National Academy of Sciences of the United States of America. 94:1997;9926-9931.
57. Dingwall C. Spotlight on BACE: The secretases as targets for treatment in Alzheimer disease. Journal of Clinical Investigation. 108:2001;1243-1246.
58. Donoviel D.B., Hadjantonakis A.K., Ikeda M., Zheng H., Hyslop P.S., Bernstein A. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes & Development. 13:1999;2801-2810.
59. Dow D.J., Lindsey N., Cairns N.J., Brayne C., Robinson D., Huppert F.A., Paykel E.S., Xuereb J., Wilcock G., Whittaker J.L., Rubinsztein D.C. Alpha 2-macroglobulin polymorphism and Alzheimer disease risk in the UK. Nature Genetics. 22:1999;16-17.
60. Du Y., Ni B., Glinn M., Dodel R.C., Bales K.R., Zhang Z., Hyslop P.A., Paul S.M. α2-Macroglobulin as a β-amyloid peptide-binding plasma protein. Journal of Neurochemistry. 69:1997;299-305.
61. Duff K., Eckman C., Zehr C., Yu X., Prada C.M., Perez-tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M.N., Holcomb L., Refolo L., Zenk B., Hardy J., Younkin S. Increased amyloid-beta 42(43) in brains of mice expressing mutant presenilin 1. Nature. 383:1996;710-713.
62. Edbauer D., Willem M., Lammich S., Steiner H., Haass C. Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD). The Journal of Biological Chemistry. 277:2002;13389-13393.
63. Edbauer D., Winkler E., Haass C., Steiner H. Presenilin and nicastrin regulate each other and determine amyloid beta-peptide production via complex formation. Proceedings of the National Academy of Sciences of the United States of America. 99:2002;8666-8671.
64. Ehehalt R., Michel B., De Pietri Tonelli D., Zacchetti D., Simons K., Keller P. Splice variants of the beta-site APP-cleaving enzyme BACE1 in human brain and pancreas. Biochemical and Biophysical Research Communications. 293:2002;30-37.
65. Eriksson S., Janciauskiene S., Lannfelt L. Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation. Proceedings of the National Academy of Sciences of the United States of America. 92:1995;2313-2317.
66. Ertekin-Taner N., Graff-Radford N., Younkin L.H., Eckman C., Baker M., Adamson J., Ronald J., Blangero J., Hutton M., Younkin S.G. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science. 290:2000;2303-2304.
67. Espinosa R. III, Lemons R.S., Perlman R.K., Kuo W.-L., Rosner M.R., Le Beau M.M. Localization of the gene encoding insulin-degrading enzyme to human chromosome 10, bands q23-q25. Cytogenetics and Cell Genetics. 57:1991;184-186.
68. Evans K.C., Berger E.P., Cho C.G., Weisgraber K.H., Lansbury P.T. Jr. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 92:1995;763-767.
69. Ezquerra M., Blesa R., Tolosa E., Ballesta F., Oliva R. Alpha-antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population. Neuroscience Letters. 240:1998;107-109.
70. Fagan R., Swindells M., Overington J., Weir M. Nicastrin, a presenilin-interacting protein, contains an aminopeptidase/transferrin receptor superfamily domain. Trends in Biochemical Sciences. 26:2001;213-214.
71. Fahrenholz F., Gilbert S., Kojro E., Lammich S., Postina R. Alpha-secretase activity of the disintegrin metalloprotease ADAM 10. Influences of domain structure. Annals of the New York Academy of Sciences. 920:2000;215-222.
72. Farzan M., Schnitzler C.E., Vasilieva N., Leung D., Choe H. BACE2, a beta-secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proceedings of the National Academy of Sciences of the United States of America. 97:2000;9712-9717.
73. Fischer F., Molinari M., Bodendorf U., Paganetti P. The disulphide bonds in the catalytic domain of BACE are critical but not essential for amyloid precursor protein processing activity. Journal of Neurochemistry. 80:2002;1079-1088.
74. Fluhrer R., Capell A., Westmeyer G., Willem M., Hartung B., Condron M.M., Teplow D.B., Haass C., Walter J. A non-amyloidogenic function of BACE-2 in the secretory pathway. Journal of Neurochemistry. 81:2002;1011-1020.
75. Forman M.S., Cook D.G., Leight S., Doms R.W., Lee V.M. Differential effects of the Swedish mutant amyloid precursor protein on beta-amyloid accumulation and secretion in neurons and nonneuronal cells. The Journal of Biological Chemistry. 272:1997;32247-32253.
76. Francis R., McGrath G., Zhang J., Ruddy D.A., Sym M., Apfeld J., Nicoll M., Maxwell M., Hai B., Ellis M.C., Parks A.L., Xu W., Li J., Gurney M., Myers R.L., Himes C.S., Hiebsch R., Ruble C., Nye J.S., Curtis D. Aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Development of Cell. 3:2002;85-97.
77. Fraser P.E., Nguyen J.T., McLachlan D.R., Abraham C.R., Kirschner D.A. Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific, and induces fibril disaggregation in vitro. Journal of Neurochemistry. 61:1993;298-305.
78. Fukushima Y., Bell G.I., Shows T.B. The polymorphic human alpha-2-macroglobulin gene (A2M) is located in chromosome region 12p12.3-p13.3. Cytogenetics and Cell Genetics. 48:1988;58-59.
79. Gabuzda D., Busciglio J., Yankner B.A. Inhibition of beta-amyloid production by activation of protein kinase C. Journal of Neurochemistry. 61:1993;2326-2329.
80. Galbiati F., Volonte D., Gil O., Zanazzi G., Salzer J.L., Sargiacomo M., Scherer P.E., Engelman J.A., Schlegel A., Parenti M., Okamoto T., Lisanti M.P. Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: Caveolin-2 is up-regulated in response to cell injury. Proceedings of the National Academy of Sciences of the United States of America. 95:1998;10257-10262.
81. Gearing M., Mori H., Mirra S.S. Abeta-peptide length and apolipoprotein E genotype in Alzheimer's disease. Annals of Neurology. 39:1996;395-399.
82. Glenner G.G., Wong C.W., Quaranta V., Eanes E.D. The amyloid deposits in Alzheimer's disease: Their nature and pathogenesis. Applied Pathology. 2:1984;357-369.
83. Goldgaber D., Lerman M.I., McBride O.W., Saffiotti U., Gajdusek D.C. Characterization and chromosomal location of a cDNA encoding brain amyloid of Alzheimer's disease. Science. 235:1987;877-880.
84. Gouras G.K., Xu H., Jovanovic J.N., Buxbaum J.D., Wang R., Greengard P., Relkin N.R., Gandy S. Generation and regulation of beta-amyloid peptide variants by neurons. Journal of Neurochemistry. 71:1998;1920-1925.
85. Goutte C. Genetics leads the way to the accomplices of presenilins. Development of Cell. 3:2002;6-7.
86. Guo Q., Sopher B.L., Furukawa K., Pham D.G., Robinson N., Martin G.M., Mattson M.P. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: Involvement of calcium and oxyradicals. Journal of Neuroscience. 17:1997;4212-4222.
87. Haass C., Schlossmacher M., Hung A.Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B., Lieberburg I., Koo E.H., Schenk D., Teplow D., Selkoe D.J. Amyloid-β peptide is produced by cultured cells during normal metabolism. Nature. 359:1992;322-325.
88. Haines J.L., Pritchard M.L., Saunders A.M., Schildkraut J.M., Growdon J.H., Gaskell P.C., Farrer L.A., Auerbach S.A., Gusella J.F., Locke P.A., Rosi B.L., Yamaoka L., Small G.W., Conneally P.M., Roses A.D., Pericak-Vance M.A. No genetic effect of alpha1-antichymotrypsinin Alzheimer's disease. Genomics. 33:1996;53-56.
89. Haniu M., Denis P., Young Y., Mendiaz E.A., Fuller J., Hui J.O., Bennett B.D., Kahn S., Ross S., Burgess T., Katta V., Rogers G., Vassar R., Citron M. Characterization of Alzheimer's beta-secretase protein BACE. A pepsin family member with unusual properties. The Journal of Biological Chemistry. 275:2000;21099-21106.
90. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapy. Science. 297:2002;353-356.
91. Hattori C., Asai M., Oma Y., Kino Y., Sasagawa N., Saido T.C., Maruyama K., Ishiura S. BACE1 interacts with nicastrin. Biochemical and Biophysical Research Communications. 293:2002;1228-1232.
92. Herreman A., Hartmann D., Annaert W., Saftig P., Craessaerts K., Serneels L., Umans L., Schrijvers V., Checler F., Vanderstichele H., Baekelandt V., Dressel R., Cupers P., Huylebroeck D., Zwijsen A., van Leuven F., De Strooper B. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proceedings of the National Academy of Sciences of the United States of America. 96:1999;11872-11877.
93. Herreman A., Serneels L., Annaert W., Collen D., Schoonjans L., De Strooper B. Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells. Nature Cell. Biol.2:2000;461-462.
94. Herz J., Strickland D.K. LRP: A multifunctional scavenger and signalling receptor. Journal of Clinical Investigation. 108:2001;779-784.
95. Hilliker C., Overbergh L., Petit P., van Leuven F., van den Berghe H. Assignment of mouse alpha-2-macroglobulin gene to chromosome 6 band F1-G3. Mammalian Genome. 3:1992;469-471.
96. Ho L., Fukuchi K., Younkin S.G. The alternatively spliced Kunitz protease inhibitor domain alters amyloid beta protein precursor processing and amyloid beta protein production in cultured cells. The Journal of Biological Chemistry. 271:1996;30929-30934.
97. Holtzman D.M. Role of ApoE/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy. Journal of Molecular Neuroscience. 17:2001;147-155.
98. Hong L., Koelsch G., Lin X., Wu S., Terzyan S., Ghosh A.K., Zhang X.C., Tang J. Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science. 290:2000;150-153.
99. Hooper N.M., Turner A.J. The search for alpha-secretase and its potential as a therapeutic approach to Alzheimer s disease. Current Medicinal Chemistry. 9:2002;1107-1119.
100. Hotoda N., Koike H., Sasagawa N., Ishiura S. A secreted form of human ADAM9 has an alpha-secretase activity for APP. Biochemical and Biophysical Research Communications. 293:2002;800-805.
101. Howard L., Lu X., Mitchell S., Griffiths S., Glynn P. Molecular cloning of MADM: A catalytically active mammalian disintegrin-metalloprotease expressed in various cell types. The Biochemical Journal. 317:1996;45-50.
102. Howlett D.R., Simmons D.L., Dingwall C., Christie G. In search of an enzyme: The beta-secretase of Alzheimer's disease is an aspartic proteinase. Trends in Neurosciences. 23:2000;565-570.
103. Hughes S.R., Khorkova O., Goyal S., Knaeblein J., Heroux J., Riedel N.G., Sahasrabudhe S. α2-Macroglobulin associates with β-amyloid peptide and prevents fibril formation. Proceedings of the National Academy of Sciences of the United States of America. 95:1998;3275-3280.
104. Huppert S.S., Le A., Schroeter E.H., Mumm J.S., Saxena M.T., Milner L.A., Kopan R. Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1. Nature. 405:2000;966-970.
105. Huse J.T., Doms R.W. Closing in on the amyloid cascade: Recent insights into the cell biology of Alzheimer's disease. Molecular Neurobiology. 22:2000;81-98.
106. Huse J.T., Liu K., Pijak D.S., Carlin D., Lee V.M., Doms R.W. Beta-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain. The Journal of Biological Chemistry. 277:2002;16278-16284.
107. Huse J.T., Pijak D.S., Leslie G.J., Lee V.M., Doms R.W. Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease beta-secretase. The Journal of Biological Chemistry. 275:2000;33729-33737.
108. Hussain I., Powell D.J., Howlett D.R., Chapman G.A., Gilmour L., Murdock P.R., Tew D.G., Meek T.D., Chapman C., Schneider K., Ratcliffe S.J., Tattersall D., Testa T.T., Southan C., Ryan D.M., Simmons D.L., Walsh F.S., Dingwall C., Christie G. ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site. Molecular and Cellular Neuroscience. 16:2000;609-619.
109. Hussain I., Powell D., Howlett D.R., Tew D.G., Meek T.D., Chapman C., Gloger I.S., Murphy K.E., Southan C.D., Ryan D.M., Smith T.S., Simmons D.L., Walsh F.S., Dingwall C., Christie G. Identification of a novel aspartic protease (Asp 2) as beta-secretase. Molecular and Cellular Neuroscience. 14:1999;419-427.
110. Ikezu T., Trapp B.D., Song K.S., Schlegel A., Lisanti M.P., Okamoto T. Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein. The Journal of Biological Chemistry. 273:1998;10485-10495.
111. Ikezu T., Ueda H., Trapp B.D., Nishiyama K., Sha J.F., Volonte D., Galbiati F., Byrd A.L., Bassell G., Serizawa H., Lane W.S., Lisanti M.P., Okamoto T. Affinity-purification and characterization of caveolins from the brain: Differential expression of caveolin-1, -2, and -3 in brain endothelial and astroglial cell types. Brain Research. 804:1998;177-1792.
112. Imbimbo B.P. β-Amyloid immunization approaches for Alzheimer's disease. Drug Development and Research. 56:2002;150-162.
113. Itabashi S., Arai H., Matsui T., Matsushita S., Muramatsu T., Higuchi S., Trojanowski J.Q., Sasaki H. Absence of association of alpha1-antichymotrypsin polymorphisms with Alzheimer's disease: A report on autopsy-confirmed cases. Experimental Neurology. 151:1998;237-240.
114. Iwata N., Tsubuki S., Takaki Y., Shirotani K., Lu B., Gerard N.P., Gerard C., Hama E., Lee H.J., Saido T.C. Metabolic regulation of brain Abeta by neprilysin. Science. 292:2001;1550-1552.
115. Iwata N., Tsubuki S., Takaki Y., Watanabe K., Sekiguchi M., Hosoki E., Kawashima-Morishima M., Lee H.J., Hama E., Sekine-Aizawa Y., Saido T.C. Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition. Nature Medicine. 6:2000;143-150.
116. Janciauskiene S., Eriksson S., Wright H.T. A specific structural interaction of Alzheimer's peptide A beta 1-42 with alpha 1-antichymotrypsin. Nature Structural Biology. 3:1996;668-671.
117. 1-antichymotrypsin and transforms it from an inhibitor to substrate. The Journal of Biological Chemistry. 273:1998;28360-28364.
118. Janicki S., Monteiro M.J. Increased apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation (N141I). The Journal of Cell Biology. 139:1997;485-495.
119. Jarrett J.T., Berger E.P., Lansbury P.T. Jr. The C-terminus of the beta protein is critical in amyloidogenesis. Annals of the New York of Academy of Sciences. 695:1993;144-148.
120. Jenkins E.C., Devine-Gage E.A., Robakis N.K., Yao X.-L., Brown W.T., Houck G.E. Jr., Wolfe G., Ramakrishna N., Silverman W.P., Wisniewski H.M. Fine mapping of an Alzheimer disease-associated gene encoding beta-amyloid protein. Biochemical and Biophysical Research Communications. 151:1988;1-8.
121. Kalsheker N.A. Alpha-1-antichymotrypsin. The International Journal of Biochemistry & Cell Biology. 28:1996;961-964.
122. Kaether C., Lammich S., Edbauer D., Ertl M., Rietdorf J., Capell A., Steiner H., Haass C. Presenilin-1 affects trafficking and processing of betaAPP and is targeted in a complex with nicastrin to the plasma membrane. The Journal of Cell Biology. 158:2002;551-561.
123. Kamal A., Almenar-Queralt A., LeBlanc J.F., Roberts E.A., Goldstein L.S. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature. 414:2001;643-648.
124. Kamboh M.I., Sanghera D.K., Ferrel R.E., DeKosky S.T. APOE*4-associated Alzheimer's disease risk is modified by alpha-1-antichymotrypsin polymorphism. Nature Genetics. 10:1995;486-488.
125. Kan C.-C., Solomon E., Belt K.T., Chain A.C., Hiorns L.R., Fey G. Nucleotide sequence of cDNA encoding human alpha-2-macroglobulin and assignment of the chromosomal locus. Proceedings of the National Academy of Sciences of the United States of America. 82:1985;2282-2286.
126. Kang J., Lemaire H.-G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.-H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
127. Kang D.E., Pietrzik C.U., Baum L., Chevallier N., Merriam D.E., Kounnas M.Z., Wagner S.L., Troncoso J.C., Kawas C.H., Katzman R., Koo E.H. Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. Journal of Clinical Investigation. 106:2000;1159-1166.
128. Kang D.E., Saitoh T., Chen X., Xia Y., Masliah E., Hansen L.A., Thomas R.G., Thal L.J., Katzman R. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology. 49:1997;56-61.
129. Katayama T., Imaizumi K., Sato N., Miyoshi K., Kudo T., Hitomi J., Morihara T., Yoneda T., Gomi F., Mori Y., Nakano Y., Takeda J., Tsuda T., Itoyama Y., Murayama O., Takashima A., St. George-Hyslop P.H., Takeda M., Tohyama M. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nature Cell Biology. 1:1999;479-485.
130. Kawamura Y., Kikuchi A., Takada R., Takada S., Sudoh S., Shibamoto S., Yanagisawa K., Komano H. Inhibitory effect of a presenilin 1 mutation on the Wnt signalling pathway by enhancement of beta-catenin phosphorylation. European Journal of Biochemistry. 268:2001;3036-3041.
131. Kehoe P., Wavrant-De Vrieze F., Crook R., Wu W.S., Holmans P., Fenton I., Spurlock G., Norton N., Williams H., Williams N., Lovestone S., Perez-Tur J., Hutton M., Chartier-Harlin M.C., Shears S., Roehl K., Booth J., Van Voorst W., Ramic D., Williams J., Goate A., Hardy J., Owen M.J. A full genome scan for late onset Alzheimer disease. Human Molecular Genetics. 8:1999;237-245.
132. Kienlen-Campard P., Octave J.N. Correlation between beta-amyloid peptide production and human APP-induced neuronal death. Peptides. 23:2002;1199-1204.
133. Kim J.W., Chang T.S., Lee J.E., Huh S.H., Yeon S.W., Yang W.S., Joe C.O., Mook-Jung I., Tanzi R.E., Kim T.W., Choi E.J. Negative regulation of the SAPK/JNK signaling pathway by presenilin 1. The Journal of Cell Biology. 153:2001;457-463.
134. Kim T.W., Pettingell W.H., Hallmark O.G., Moir R.D., Wasco W., Tanzi R.E. Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells. The Journal of Biological Chemistry. 272:1997;11006-11010.
135. Kimberly W.T., LaVoie M.J., Ostaszewski B.L., Ye W., Wolfe M.S., Selkoe D.J. Complex N-linked glycosylated nicastrin associates with active gamma-secretase and undergoes tight cellular regulation. The Journal of Biological Chemistry. 277:2002;35113-35117.
136. Kleiner D.E. Jr., Stetler-Stevenson W.G. Structural biochemistry and activation of matrix metalloproteases. Current Opinion in Cell Biology. 5:1993;891-897.
137. Knauer M.F., Orlando R.A., Glabe C.G. Cell surface APP751 forms complexes with protease nexin 2 ligands and is internalized via the low density lipoprotein receptor-related protein (LRP). Brain Research. 740:1996;6-14.
138. Koike H., Tomioka S., Sorimachi H., Saido T.C., Maruyama K., Okuyama A., Fujisawa-Sehara A., Ohno S., Suzuki K., Ishiura S. Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. The Biochemical Journal. 343:1999;371-375.
139. Kojro E., Gimpl G., Lammich S., Marz W., Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proceedings of the National Academy of Sciences of the United States of America. 98:2001;5815-5820.
140. Kopan R., Goate A. Aph-2/nicastrin: An essential component of gamma-secretase and regulator of Notch signalling and Presenilin localization. Neuron. 33:2002;321-324.
141. Kordula T., Bugno M., Rydel R.E., Travis J. Mechanism of interleukin-1- and tumor necrosis factor alpha-dependent regulation of the alpha-1-antichymotrypsin gene in human astrocytes. Journal of Neuroscience. 20:2000;7510-7516.
142. Kordula T., Rydel R., Brigham E., Horn F., Heinrich P., Travis J. Oncostatin M, and the interleukin-6 (IL-6), and soluble IL-6 receptor complex regulate alpha1-antichymotrypsin expression in human cortical astrocytes. The Journal of Biological Chemistry. 273:1998;4112-4118.
143. Korenberg J.R., Pulst S.-M., Neve R.L., West R. The Alzheimer amyloid precursor protein maps to human chromosome 21 bands q21.105-q21.05. Genomics. 5:1989;124-127.
144. Kounnas M.Z., Moir R.D., Rebeck G.W., Bush A.I., Argraves W.S., Tanzi R.E., Hyman B.T., Strickland D.K. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta amyloid precursor protein and mediates its degradation. Cell. 82:1995;331-340.
145. Kovacs D.M. Alpha2-macroglobulin in late-onset Alzheimer's disease. Experimental Gerontology. 35:2000;473-479.
146. Kristensen T., Moestrup S.K., Gliemann J., Bendtsen L., Sand O., Sottrup-Jensen L. Evidence that the newly cloned low-density-lipoprotein receptor related protein (LRP) is the alpha-2-macroglobulin receptor. FEBS Letters. 276:1990;151-155.
147. Kulic L., Walter J., Multhaup G., Teplow D.B., Baumeister R., Romig H., Capell A., Steiner H., Haass C. Separation of presenilin function in amyloid beta-peptide generation and endoproteolysis of Notch. Proceedings of the National Academy of Sciences of the United States of America. 97:2000;5913-5918.
148. Kurochkin I.V. Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme. FEBS Letters. 427:1998;153-156.
149. Kurochkin I.V. Insulin-degrading enzyme: Embarking on amyloid destruction. Trends in Biochemical Sciences. 26:2001;421-425.
150. Kurochkin I.V., Goto S. Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Letters. 345:1994;33-37.
151. Lah J.J., Levey A.I. Endogenous presenilin-1 targets to endocytic rather than biosynthetic compartments. Molecular and Cellular Neuroscience. 16:2000;111-126.
152. Lamb H., Christie J., Singleton A.B., Leake A., Perry R.H., Ince P.G., McKeith I.G., Melton L.M., Edwardson J.A., Morris C.M. Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases. Neurology. 50:1998;388-391.
153. Lambert J.-C., Mann D., Goumidi L., Harris J., Amouyel P., Iwatsubo T., Lendon C., Chartier-Harlin M.-C. Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease. The Lancet. 357:2001;608-609.
154. Lambert J.-C., Mann D.M., Harris J.M., Chartier-Harlin M.C., Cumming A., Coates J., Lemmon H., St. Clair D., Iwatsubo T., Lendon C. The -48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased Abeta load in brain. Journal of Medicinal Genetics. 38:2001;353-355.
155. Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C., Fahrenholz F. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proceedings of the National Academy of Sciences of the United States of America. 96:1999;3922-3927.
156. Ledesma M.D., Da Silva J.S., Crassaerts K., Delacourte A., De Strooper B., Dotti C.G. Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains. EMBO Reports. 1:2000;530-535.
157. Lee S.J., Liyanage U., Bickel P.E., Xia W., Lansbury P.T. Jr., Kosik K.S. A detergent-insoluble membrane compartment contains A beta in vivo. Nature Medicine. 4:1998;730-734.
158. Leem J.Y., Vijayan S., Han P., Cai D., Machura M., Lopes K.O., Veselits M.L., Xu H., Thinakaran G. Presenilin 1 is required for maturation and cell surface accumulation of nicastrin. The Journal of Biological Chemistry. 277:2002;19236-19240.
159. Levy-Lahad E., Poorkaj P., Wang K., Fu Y.H., Oshima J., Mulligan J., Schellenberg G.D. Genomic structure and expression of STM2, the chromosome 1 familial Alzheimer disease gene. Genomics. 34:1996;198-204.
160. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C., Jondro P.D., Schmidt S.D., Wang K., Crowley A.C., Fu Y.-H., Guenette S.Y., Galas D., Nemens E., Wijsman E.M., Bird T.D., Schellenberg G.D., Tanzi R.E. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995;973-977.
161. Levy-Lahad E., Wijsman E.M., Nemens E., Anderson L., Goddard K.A.B., Weber J.L., Bird T.D., Schellenberg G.D. A familial Alzheimer's disease locus on chromosome 1. Science. 269:1995;970-973.
162. Li X., Greenwald I. Additional evidence for an eight-transmembrane-domain topology for Caenorhabditis elegans and human presenilins. Proceedings of the National Academy of Sciences of the United States of America. 95:1998;7109-7114.
163. Li Y.M., Lai M.T., Xu M., Huang Q., DiMuzio-Mower J., Sardana M.K., Shi X.P., Yin K.C., Shafer J.A., Gardell S.J. Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. Proceedings of the National Academy of Sciences of the United States of America. 97:2000;6138-6143.
164. Li Y.M., Xu M., Lai M.T., Huang Q., Castro J.L., DiMuzio-Mower J., Harrison T., Lellis C., Nadin A., Neduvelil J.G., Register R.B., Sardana M.K., Shearman M.S., Smith A.L., Shi X.P., Yin K.C., Shafer J.A., Gardell S.J. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature. 405:2000;689-694.
165. Li J., Xu M., Zhou H., Ma J., Potter H. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell. 90:1997;917-927.
166. Liao A., Nitsch R.M., Greenberg S.M., Finckh U., Blacker D., Albert M., Rebeck G.W., Gomez-Isla T., Clatworthy A., Binetti G., Hock C., Mueller-Thomsen T., Mann U., Zuchowski K., Beisiegel U., Staehelin H., Growdon J.H., Tanzi R.E., Hyman B.T. Genetic association of α-2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Human Molecular Genetics. 7:1998;1953-1956.
167. Licastro F., Pedrini S., Caputo L., Annoni G., Davies L.J., Ferri C., Casadei V., Grimaldi L.M. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: Peripheral inflammation or signals from the brain. Annals of Neurology. 48:2000;388-391.
168. Licastro F., Pedrini S., Govoni M., Pession A., Ferri C., Annoni G., Casadei V., Veglia F., Bertolini S., Grimaldi L.M. Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease. Neuroscience Letters. 270:1999;129-132.
169. Lin X., Koelsch G., Wu S., Downs D., Dashti A., Tang J. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proceedings of the National Academy of Sciences of the United States of America. 97:2000;1456-1460.
170. Liu K., Doms R.W., Lee V.M. Glu11 site cleavage and N-terminally truncated A beta production upon BACE overexpression. Biochemistry. 41:2002;3128-3136.
171. Luo Y., Bolon B., Kahn S., Bennett B.D., Babu-Khan S., Denis P., Fan W., Kha H., Zhang J., Gong Y., Martin L., Louis J.C., Yan Q., Richards W.G., Citron M., Vassar R. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nature Neuroscience. 4:2001;231-232.
172. Ma J., Brewer H.B.J., Potter H. Alzheimer A beta neurotoxicity: Promotion by antichymotrypsin, ApoE4 inhibition by A beta-related peptides. Neurobiology of Aging. 17:1996;773-780.
173. Ma J., Yee A., Brewer H.B.J., Das S., Potter H. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature. 372:1994;92-94.
174. Mahadeva R., Sharples L., Ross-Russell R.I., Webb A.K., Bilton D., Lomas D.A. Association of alpha (1)-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis. Thorax. 56:2001;53-58.
175. Maiorini A.F., Gaunt M.J., Jacobsen T.M., McKay A.E., Waldman L.D., Raffa R.B. Potential novel targets for Alzheimer pharmacotherapy. I. Secretases. Journal of Clinical Pharmacy and Therapeutics. 27:2002;169-183.
176. Marcinkiewicz M., Seidah N.G. Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain. Journal of Neurochemistry. 75:2000;2133-2143.
177. Marynen P., Zhang J., Devriendt K., Cassiman J.-J. Alpha-2-macroglobulin, pregnancy zone protein and an alpha-2-macroglobulin pseudogene map to chromosome 12p12.2-p13. Cytogenetics and Cell Genetics. 51:1989;1040.
178. Matthijs G., Devriendt K., Cassiman J.-J., van den Berghe H., Marynen P. Structure of the human alpha-2 macroglobulin gene and its promotor. Biochemical and Biophysical Research Communications. 184:1992;596-603.
179. Matthijs G., Marynen P.A. A deletion polymorphism in the human α-2-macroglobulin (A2M) gene. Nucleic Acids Research. 19:1991;5102.
180. May P., Reddy Y.K., Herz J. Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. The Journal of Biological Chemistry. 27:2002;18736-18743.
181. Meinke P.T., Colletti S.L., Doss G., Myers R.W., Gurnett A.M., Dulski P.M., Darkin-Rattray S.J., Allocco J.J., Galuska S., Schmatz D.M., Wyvratt M.J., Fisher M.H. Susceptibility locus for Alzheimer's disease on chromosome 10. Science. 290:2000;2304-2305.
182. Moir R.D., Lynch T., Bush A.I., Whyte S., Henry A., Portbury S., Multhaup G., Small D.H., Tanzi R.E., Beyreuther K., Masters C.L. Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain. The Journal of Biological Chemistry. 273:1998;5013-5019.
183. Moore A.M., O'Banion M.K. Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease. Advanced Drug Delivery Reviews. 54:2002;1627-1656.
184. Morgan K., Licastro F., Tilley L., Ritchie A., Morgan L., Pedrini S., Kalsheker N. Polymorphism in the alpha-1-antichymotrypsin (ACT) gene promoter: Effect on expression in transfected glial and liver cell lines and plasma ACT concentrations. Human Genetics. 109:2001;303-310.
185. Moss M.L., Jin S.L., Becherer J.D., Bickett D.M., Burkhart W., Chen W.J., Hassler D., Leesnitzer M.T., McGeehan G., Milla M., Moyer M., Rocque W., Seaton T., Schoenen F., Warner J., Willard D. Structural features and biochemical properties of TNF-alpha converting enzyme (TACE). Journal of Neuroimmunology. 72:1997;127-129.
186. Motonaga K., Itoh M., Becker L.E., Goto Y., Takashima S. Elevated expression of beta-site amyloid precursor protein cleaving enzyme 2 in brains of patients with Down syndrome. Neuroscience Letters. 326:2002;64-66.
187. Mucke L., Masliah E., Yu G., Mallory M., Rockenstein E.M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., McConlogue L. High-level neuronal expression of Abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. Journal of Neuroscience. 20:2000;4050-4058.
188. Mucke L., Yu G., McConlogue L., Rockenstein E.M., Abraham C.R., Masliah E. Astroglial expression of human alpha(1)-antichymotrypsin enhances Alzheimer-like pathology in amyloid protein precursor transgenic mice. American Journal of Pathology. 157:2000;2003-2010.
189. Murphy G.M., Sullivan E.V., Gallagher-Thompson D., Thompson L.W., van Duijn C.M., Forno L.S., Ellis W.G., Jagust W.J., Yesavage J., Tinklenberg J.R. No association between the alpha1-antichymotrypsin A allele and Alzheimer's disease. Neurology. 48:1997;1313-1316.
190. Murphy M.P., Uljon S.N., Fraser P.E., Fauq A., Lookingbill H.A., Findlay K.A., Smith T.E., Lewis P.A., McLendon D.C., Wang R., Golde T.E. Presenilin 1 regulates pharmacologically distinct gamma-secretase activities. Implications for the role of presenilin in gamma-secretase cleavage. The Journal of Biological Chemistry. 275:2000;26277-26284.
191. Mushegian A. Refining structural and functional predictions for secretasome components by comparative sequence analysis. Proteins. 47:2002;69-74.
192. Myklebost O., Arheden K., Rogne S., Geurts van Kessel A., Mandahl N., Herz J., Stanley K., Heim S., Mitelman F. The gene for the human putative apoE receptor is on chromosome 12 in the segment q13-14. Genomics. 5:1989;65-69.
193. Myllykangas L., Polvikoski T., Sulkava R., Verkkoniemi A., Crook R., Tienari P.J., Pusa A.K., Niinisto L., O'Brien P., Kontula K., Hardy J., Haltia M., Perez-Tur J. Genetic association of α2-macroglobulin with Alzheimer's disease in a Finnish elderly population. Annals of Neurology. 46:1999;382-390.
194. Nacmias B., Marcon G., Tedde A., Forleo P., Latorraca S., Piacentini S., Amaducci L., Sorbi S. Implication of alpha1-antichymotrypsin polymorphism in familial Alzheimer's disease. Neuroscience Letters. 244:1998;85-88.
195. Narita M., Holtzman D.M., Schwartz A.L., Bu G. Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. Journal of Neurochemistry. 69:1997;1904-1911.
196. Naruse S., Thinakaran G., Luo J.J., Kusiak J.W., Tomita T., Iwatsubo T., Qian X., Ginty D.D., Price D.L., Borchelt D.R., Wong P.C., Sisodia S.S. Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron. 21:1998;1213-1221.
197. Naslund J., Haroutunian V., Mohs R.R., Davis K.L., Davies P., Greengard P., Buxbaum J.D. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. The Journal of the American Medical Association. 283:2000;1571-1577.
198. Naslund J., Schierhorn A., Hellman U., Lannfelt L., Roses A.D., Tjernberg L.O., Silberring J., Gandy S.E., Winblad B., Greengard P., Nordstedt C., Terenius L. Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proceedings of the National Academy of Sciences of the United States of America. 91:1994;8378-8382.
199. Nilsson L.N., Bales K.R., DiCarlo G., Gordon M.N., Morgan D., Paul S.M., Potter H. Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease. Journal of Neuroscience. 21:2001;1444-1451.
200. Nitsch R.M., Slack B.E., Wurtman R.J., Growdon J.H. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science. 258:1992;304-306.
201. Niwa M., Sidrauski C., Kaufman R.J., Walter P. A role for presenilin-1 in nuclear accumulation of Ire1 fragments and induction of the mammalian unfolded protein response. Cell. 99:1999;691-702.
202. Nordstedt C., Lake S., Winblad B. Alzheimer's disease - an amyloid disease of the brain. Lakartidningen. 89:1992;4255-4260.
203. Nowotny P., Gorski S.M., Han S.W., Philips K., Ray W.J., Nowotny V., Jones C.J., Clark R.F., Cagan R.L., Goate A.M. Posttranslational modification and plasma membrane localization of the Drosophila melanogaster presenilin. Molecular and Cellular Neuroscience. 15:2000;88-98.
204. Nunan J., Small D.H. Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Letters. 483:2000;6-10.
205. Oda M., Morino H., Maruyama H., Terasawa H., Izumi Y., Torii T., Sasaki K., Nakamura S., Kawakami H. Dinucleotide repeat polymorphisms in the neprilysin gene are not associated with sporadic Alzheimer's disease. Neuroscience Letters. 320:2002;105-107.
206. Parvathy S., Karran E.H., Turner A.J., Hooper N.M. The secretases that cleave angiotensin converting enzyme and the amyloid precursor protein are distinct from tumour necrosis factor-alpha convertase. FEBS Letters. 43:1998;63-65.
207. Patterson D., Gardiner K., Kao F.T., Tanzi R., Watkins P., Gusella J.F. Mapping of the gene encoding the beta-amyloid precursor protein and its relationship to the Down syndrome region of chromosome 21. Proceedings of the National Academy of Sciences of the United States of America. 85:1988;8266-8270.
208. Perez A., Morelli L., Cresto J.C., Castano E.M. Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains. Neurochemistry Research. 25:2000;247-255.
209. Perez R.G., Zheng H., Van der Ploeg L.H., Koo E.H. The beta-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity. Journal of Neuroscience. 17:1997;9407-9414.
210. Periz G., Fortini M.E. Proteolysis in Alzheimer's disease. Can plasmin tip the balance? EMBO Reports. 1:2000;477-478.
211. Petit A., Bihel F., Alves da Costa C., Pourquie O., Checler F., Kraus J.L. New protease inhibitors prevent gamma-secretase-mediated production of Abeta40/42 without affecting Notch cleavage. Nature Cell Biology. 3:2001;507-511.
212. Pike C.J., Overman M.J., Cotman C.W. Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro. The Journal of Biological Chemistry. 270:1995;23895-23898.
213. Qiu W.Q., Borth W., Ye Z., Haass C., Teplow D.B., Selkoe D.J. Degradation of amyloid-β protein by a serine protease-2-macroglobulin complex. The Journal of Biological Chemistry. 271:1996;8443-8451.
214. Qiu W.Q., Walsh D.M., Ye Z., Vekrellis K., Zhang J., Podlisny M.B., Rosner M.R., Safavi A., Hersh L.B., Selkoe D.J. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. The Journal of Biological Chemistry. 273:1998;32730-32738.
215. Rabin M., Watson M., Breg W.R., Kidd V., Woo S.L.C., Ruddle F.H. Human alpha-1-antichymotrypsin and alpha-1-antitrypsin (PI) genes map to the same region on chromosome 14. Cytogenetics and Cell Genetics. 40:1985;728. (Abstract).
216. Ratovitski T., Slunt H.H., Thinakaran G., Price D.L., Sisodia S.S., Borchelt D.R. Endoproteolytic processing and stabilization of wild-type and mutant presenilin. The Journal of Biological Chemistry. 272:1997;24536-24541.
217. Ray W.J., Yao M., Mumm J., Schroeter E.H., Saftig P., Wolfe M., Selkoe D.J., Kopan R., Goate A.M. Cell surface presenilin-1 participates in the gamma-secretase-like proteolysis of Notch. The Journal of Biological Chemistry. 274:1999;36801-36807.
218. Reuning U., Magdolen V., Wilhelm O., Fischer K., Lutz V., Graeff H., Schmitt M. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis. International Journal of Oncology. 13:1998;893-906.
219. Robakis N.K., Ramakrishna N., Wolfe G., Wisniewski H.M. Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. Proceedings of the National Academy of Sciences of the United States of America. 84:1987;4190-4194.
220. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., Mar L., Sorbi S., Nacmias B., Piacentini S., Amaducci L., Chumakov I., Cohen D., Lannfelt L., Fraser P.E., Rommens J.M., St. George-Hyslop P.H. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 376:1995;775-778.
221. Rogaev E.I., Sherrington R., Wu C., Levesque G., Liang Y., Rogaeva E.A., Ikeda M., Holman K., Lin C., Lukiw W.J., de Jong P.J., Fraser P.E., Rommens J.M., St. George-Hyslop P.H. Analysis of the 5′ sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease. Genomics. 40:1997;415-424.
222. Rogaeva E.A., Premkumar S., Grubber J., Serneels L., Scott W.K., Kawarai T., Song Y.Q., Hill D.M., Abou-Donia S.M., Martin E.R., Vance J.J., Yu G., Orlacchio A., Pei Y., Nishimura M., Supala A., Roberge B., Saunders A.M., Roses A.D., Schmechel D., Crane-Gatherum A., Sorbi S., Bruni A., Small G.W., Conneally P.M., Haines J.L., Van Leuven F., St. George-Hyslop P.H., Farrer L.A., Pericak-Vance M.A. α-2-Macroglobulin insertion-deletion polymorphism in Alzheimer disease. Nature Genetics. 22:1999;19-22.
223. Rogers J., Webster S., Lue L.F., Brachova L., Civin W.H., Emmerling M., Shivers B., Walker D., McGeer P. Inflammation and Alzheimer's disease pathogenesis. Neurobiology of Aging. 17:1996;681-686.
224. Rojas-Fernandez C.H., Chen M., Fernandez H.L. Implications of amyloid precursor protein and subsequent β-amyloid production to the pharmacotherapy of Alzheimer's disease. Pharmacotherapy. 22:2002;1547-1563.
225. Rudrasingham V., Wavrant-De Vrieze F., Lambert J.C., Chakraverty S., Kehoe P., Crook R., Amouyel P., Wu W., Rice F., Perez-Tur J., Frigard B., Morris J.C., Carty S., Petersen R., Cottel D., Tunstall N., Holmans P., Lovestone S., Chartier-Harlin M.C., Goate A., Hardy J., Owen M.J., Williams J. Alpha-2macroglobulin gene and Alzheimer disease. Nature Genetics. 22:1999;17-19.
226. Sanan D.A., Weisgraber K.H., Russell S.J., Mahley R.W., Huang D., Saunders A., Schmechel D., Wisniewski T., Frangione B., Roses A.D., Strittmatter W.J. Apolipoprotein E associates with beta-amyloid peptide of Alzheimer's disease to form novel monofibrils: Isoform apoE4 associates more efficiently than apoE3. Journal of Clinical Investigation. 94:1994;860-869.
227. Schenk D. Alzheimer's disease. A partner for presenilin. Nature. 407:2000;34-35.
228. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., Seubert P. Immunisation with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 400:1999;173-177.
229. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Medicine. 2:1996;864-870.
230. Schmaier A.H., Dahl L.D., Rozemuller A.J.M., Roos R.A.C., Wagner S.L., Chung R., van Nostrand W.E. Protease nexin-2/amyloid-beta protein precursor: A tight-binding inhibitor of coagulation factor Ixa. Journal of Clinical Investigation. 92:1993;2540-2545.
231. Schroeter E.H., Kisslinger J.A., Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature. 393:1998;382-386.
232. Schwarzman A.L., Singh N., Tsiper M., Gregori L., Dranovsky A., Vitek M.P., Glabe C.G., St. George-Hyslop P.H., Goldgaber D. Endogenous presenilin 1 redistributes to the surface of lamellipodia upon adhesion of Jurkat cells to a collagen matrix. Proceedings of the National Academy of Sciences of the United States of America. 96:1999;7932-7937.
233. Seidah N.G., Chretien M. Proprotein and prohormone convertases: A family of subtilases generating diverse bioactive polypeptides. Brain Research. 848:1999;45-62.
234. Selkoe D.J. Alzheimer's disease: Genes, proteins, and therapy. Physiological Reviews. 81:2001a;741-766.
235. Selkoe D.J. Clearing the brain's amyloid cobwebs. Neuron. 32:2001b;177-180.
236. Selkoe D.J., Schenk D. Alzheimer's disease: Molecular understanding predicts amyloid-based therapeutics. Annual Review of Pharmacology and Toxicology. 43:2003;545-584.
237. Seubert P., Oltersdorf T., Lee M.G., Barbour R., Blomquist C., Davis D.L., Bryant K., Fritz L.C., Galasko D., Thal L.J., Lieberburg I., Schenk D.B. Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature. 361:1993;260-263.
238. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M.G., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Selkoe D.J., Lieberburg I., Schenk D. Isolation and quantitation of soluble Alzheimer's-peptide from biological fluids. Nature. 359:1992;325-327.
239. Shen J., Bronson R.T., Chen D.F., Xia W., Selkoe D.J., Tonegawa S. Skeletal and CNS defects in presenilin-1-deficient mice. Cell. 89:1997;629-639.
240. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.-F., Bruni A.C., Montesi M.P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R.J., Wasco W., Da Silva H.A.R., Haines J.L., Pericak-Vance M.A., Tanzi R., Roses A.D., Fraser P.E., Pommens J.M., St. George-Hyslop P.H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
241. Shi X.P., Chen E., Yin K.C., Na S., Garsky V.M., Lai M.T., Li Y.M., Platchek M., Register R.B., Sardana M.K., Tang M.J., Thiebeau J., Wood T., Shafer J.A., Gardell S.J. The pro-domain of beta-secretase does not confer strict zymogen-like properties but does assist proper folding of the protease domain. The Journal of Biological Chemistry. 276:2001;10366-10373.
242. Shibata M., Yamada S., Kumar S.R., Calero M., Bading J., Frangione B., Holtzman D.M., Miller C.A., Strickland D.K., Ghiso J., Zlokovic B.V. Clearance of Alzheimer's amyloid-β (1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. Journal of Clinical Investigation. 106:2000;1489-1499.
243. Shoji M., Golde T.E., Ghiso J., Cheung T.T., Estus S., Shaffer L.M., Cai X.D., McKay D.M., Tintner R., Frangione B., Younkin S.G. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science. 258:1992;126-129.
244. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C.G., Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proceedings of the National Academy of Sciences of the United States of America. 95:1998;6460-6464.
245. Singh N., Talalayeva Y., Tsiper M., Romanov V., Dranovsky A., Colflesh D., Rudamen G., Vitek M.P., Shen J., Yang X., Goldgaber D., Schwarzman A.L. The role of Alzheimer's disease-related presenilin 1 in intercellular adhesion. Experimental Cell Research. 263:2001;1-13.
246. Sinha S., Anderson J.P., Barbour R., Basi G.S., Caccavello R., Davis D., Doan M., Dovey H.F., Frigon N., Hong J., Jacobson-Croak K., Jewett N., Keim P., Knops J., Lieberburg I., Power M., Tan H., Tatsuno G., Tung J., Schenk D., Seubert P., Suomensaari S.M., Wang S., Walker D., Zhao J., McConlogue L., John V. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature. 402:1999;537-540.
247. Sinha S., Dovey H.F., Seubert P., Ward P.J., Balcher R.W., Blaber M., Bradshaw R.A., Arici M., Mobley W.C., Lieberburg I. The protease inhibitory properties of the Alzheimer's β-amyloid precursor protein. The Journal of Biological Chemistry. 265:1990;8983-8985.
248. Slack B.E., Ma L.K., Seah C.C. Constitutive shedding of the amyloid precursor protein ectodomain is up-regulated by tumour necrosis factor-alpha converting enzyme. The Biochemical Journal. 357:2001;787-794.
249. Small D.H. Is gamma-secretase a multienzyme complex for membrane protein degradation? Models and speculations. Peptides. 23:2002;1317-1321.
250. Smine A., Xu X., Nishiyama K., Katada T., Gambetti P., Yadav S.P., Wu X., Shi Y.C., Yasuhara S., Homburger V., Okamoto T. Regulation of brain G-protein by Alzheimer's disease gene presenilin-1. The Journal of Biological Chemistry. 273:1998;16281-16288.
251. Solans A., Estivill X., de La Luna S. A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer's amyloid precursor protein beta-secretase. Cytogenetics and Cell Genetics. 89:2000;177-184.
252. Song W., Nadeau P., Yuan M., Yang X., Shen J., Yankner B.A. Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations. Proceedings of the National Academy of Sciences of the United States of America. 96:1999;6959-6963.
253. Song E.S., Mukherjee A., Juliano M.A., Pyrek J.S., Goodman J.P. Jr., Juliano L., Hersh L.B. Analysis of the subsite specificity of rat insulysin using fluorogenic peptide substrates. The Journal of Biological Chemistry. 276:2001;1152-1155.
254. Steiner H., Haass C. Intramembrane proteolysis by presenilins. Nature Reviews in Molecular and Cellular Biology. 1:2000;217-224.
255. Strickland D.K., Ashcom J.D., Williams S., Burgess W.H., Migliorini M., Argraves W.S. Sequence identity between the alpha-2-macroglobulin receptor and low-density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. The Journal of Biological Chemistry. 265:1990;17401-17404.
256. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 90:1993;1977-1981.
257. Struhl G., Greenwald I. Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature. 398:1999;522-525.
258. Sun Y.X., Wright H.T., Janciauskiene S. Alpha1-antichymotrypsin/Alzheimer's peptide Abeta(1-42) complex perturbs lipid metabolism and activates transcription factors PPARgamma and NFkappaB in human neuroblastoma (Kelly) cells. Journal of Neuroscience Research. 67:2002a;511-522.
259. Sun Y.X., Wright H.T., Janciauskiene S. Glioma cell activation by Alzheimer's peptide Abeta1-42, alpha1-antichymotrypsin, and their mixture. Cellular and Molecular Life Science. 59:2002b;1734-1743.
260. Tanahashi H., Tabira T. Three novel alternatively spliced isoforms of the human beta-site amyloid precursor protein cleaving enzyme (BACE) and their effect on amyloid beta-peptide production. Neuroscience Letters. 307:2001;9-12.
261. Tang J., James M.N., Hsu I.N., Jenkins J.A., Blundell T.L. Structural evidence for gene duplication in the evolution of the acid proteases. Nature. 271:1978;618-621.
262. Tanzi R.E. Caspases land on APP: One small step for apoptosis, one giant leap for amyloidosis? Nature Neuroscience. 2:1999;585-586.
263. Tanzi R.E., Bertram L. New frontiers in Alzheimer's disease genetics. Neuron. 32:2001;181-184.
264. Tanzi R.E., McClatchey A.I., Lamperti E.D., Villa-Komaroff L., Gusella J.F., Neve R.L. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature. 331:1998;528-532.
265. Theuns J., Del-Favero J., Dermaut B., van Duijn C.M., Backhovens H., van den Broeck M.V., Serneels S., Corsmit E., van Broeckhoven C.V., Cruts M. Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression. Human Molecular Genetics. 9:2000;325-331.
266. Thinakaran G., Borchelt D.R., Lee M.K., Slunt H.H., Spitzer L., Kim G., Ratovitsky T., Davenport F., Nordstedt C., Seeger M., Hardy J., Levey A.I., Gandy S.E., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron. 17:1996;181-190.
267. Thinakaran G., Harris C.L., Ratovitski T., Davenport F., Slunt H.H., Price D.L., Borchelt D.R., Sisodia S.S. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. The Journal of Biological Chemistry. 272:1997;28415-28422.
268. Thome J., Baumer A., Kornhuber J., Rosler M., Reiderer P. Alpha-1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer's syndrome. Journal of Neural Transmission. 10:1995;207-212.
269. Tomita T., Katayama R., Takikawa R., Iwatsubo T. Complex N-glycosylated form of nicastrin is stabilized and selectively bound to presenilin fragments. FEBS Letters. 520:2002;117-121.
270. Tomita T., Maruyama K., Saido T.C., Kume H., Shinozaki K., Tokuhiro S., Capell A., Walter J., Grunberg J., Haass C., Iwatsubo T., Obata K. The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. Proceedings of the National Academy of Sciences of the United States of America. 94:1997;2025-2030.
271. Tran-Paterson R., Willard H.F., Letarte M. The common acute lymphoblastic leukemia antigen (neutral endopeptidase-3.4.24.11) gene is located on human chromosome 3. Cancer Genetics and Cytogenetics. 42:1989;129-134.
272. Travis J., Salvesen G.S. Human plasma proteinase inhibitors. Annual Reviews in Biochemistry. 52:1983;655-709.
273. Trommsdorff M., Borg J.P., Margolis B., Herz J. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. The Journal of Biological Chemistry. 273:1998;33556-33560.
274. Tucker H.M., Kihiko-Ehmann M., Caldwell J.N., Wright S., Kawarabayashi T., Price D., Walker D., Scheff S., McGillis J.P., Rydel R.E., Estus S. The plasmin system is induced by and degrades amyloid-beta aggregates. Journal of Neuroscience. 20:2000;3937-3946.
275. Tucker H.M., Kihiko-Ehmann M., Wright S., Rydel R.E., Estus S. Tissue plasminogen activator requires plasminogen to modulate amyloid-beta neurotoxicity and deposition. Journal of Neurochemistry. 75:2000;2127-2172.
276. Turner A.J., Isaac R.E., Coates D. The neprilysin (NEP) family of zinc metalloendopeptidases: Genomics and function. BioEssays. 23:2001;261-269.
277. Ulery P.G., Beers J., Mikhailenko I., Tanzi R.E., Rebeck G.W., Hyman B.T., Strickland D.K. Modulation of β-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). The Journal of Biological Chemistry. 275:2000;7410-7415.
278. Umans L., Serneels L., Overbergh L., Lorent K., van Leuven F., van den Berghe H. Targeted inactivation of the mouse 2-macroglobulin gene. The Journal of Biological Chemistry. 270:1995;80-85.
279. van Gool D., De Strooper B., van Leuven F., Triau E., Dom R. Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease. Neurobiology of Aging. 14:1993;233-237.
280. van Nostrand W.E., Porter M. Plasmin cleavage of the amyloid beta-protein: Alteration of secondary structure and stimulation of tissue plasminogen activator activity. Biochemistry. 38:1999;11570-11576.
281. Van Uden E., Kang D.E., Koo E.H., Masliah E. LDL receptor-related protein (LRP) in Alzheimer's disease: Towards a unified theory of pathogenesis. Microscopy Research and Technique. 50:2000;268-272.
282. Vassar R. The beta-secretase, BACE: A prime drug target for Alzheimer's disease. Journal of Molecular Neuroscience. 17:2001;157-170.
283. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., Teplow D.B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M.A., Biere A.L., Curran E., Burgess T., Louis J.C., Collins F., Treanor J., Rogers G., Citron M. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 286:1999;735-741.
284. Vekrellis K., Ye Z., Qiu W.Q., Walsh D., Hartley D., Chesneau V., Rosner M.R., Selkoe D.J. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. Journal of Neuroscience. 20:2000;1657-1665.
285. Vito P., Ghayur T., D'Adamio L. Generation of anti-apoptotic presenilin-2 polypeptides by alternative transcription, proteolysis, and caspase-3 cleavage. The Journal of Biological Chemistry. 272:1997;28315-28320.
286. Vito P., Wolozin B., Ganjei J.K., Iwasaki K., Lacana E., D'Adamio L. Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effect of ALG-3. The Journal of Biological Chemistry. 271:1996;31025-31028.
287. Walsh D.M., Klyubln I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowen M.J., Selkoe D.J. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 416:2002;535-539.
288. Wang X., DeKosky S.T., Ikonomovic M.D., Kamboh M.I. Distribution of plasma alpha 1-antichymotrypsin levels in Alzheimer disease patients and controls and their genetic controls. Neurobiology of Aging. 23:2002;377-382.
289. Wang X., DeKosky S.T., Luedecking-Zimmer E., Ganguli M., Kamboh M.I. Genetic variation in alpha (1)-antichymotrypsin and its association with Alzheimer's disease. Human Genetics. 110:2002;356-365.
290. Wang H.Y., Zhang F.C., Gao J.J., Fan J.B., Liu P., Zheng Z.J., Xi H., Sun Y., Gao X.C., Huang T.Z., Ke Z.J., Guo G.R., Feng G.Y., Breen G., St. Clair D., He L. Apolipoprotein E is a genetic risk factor for fetal iodine deficiency disorder in China. Molecular Psychiatry. 5:2000;363-368.
291. Weggen S., Erickson J.L., Das P., Sagi S.A., Wang R., Pietrzik C.U., Findlay K.A., Smith T.E., Murphy M.P., Butler T., Kang D.E., Marquez-Sterling N., Golde T.E., Koo E.H. A subset of NSAIDs lower amyloidogenic A beta 42 independently of cyclooxygenase activity. Nature. 414:2001;212-216.
292. Wisniewski T., Castaño E.M., Golabek A., Vogel T., Frangione B. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. American Journal of Pathology. 145:1994;1030-1035.
293. Wolfe M.S., De Los Angeles J., Miller D.D., Xia W., Selkoe D.J. Are presenilins intramembrane cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease. Biochemistry. 38:1999;11223-11230.
294. Wolfe M.S., Xia W., Ostaszewski B.L., Diehl T.S., Kimberly W.T., Selkoe D.J. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature. 398:1999;513-517.
295. Wolozin B., Iwasaki K., Vito P., Ganjei J.K., Lacana E., Sunderland T., Zhao B., Kusiak J.W., Wasco W., D'Adamio L. Participation of presenilin 2 in apoptosis: Enhanced basal activity conferred by an Alzheimer mutation. Science. 274:1996;1710-1713.
296. Wong P.C., Zheng H., Chen H., Becher M.W., Sirinathsinghji D.J., Trumbauer M.E., Chen H.Y., Price D.L., Van der Ploeg L.H., Sisodia S.S. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature. 387:1997;288-292.
297. Yan R., Bienkowski M.J., Shuck M.E., Miao H., Tory M.C., Pauley A.M., Brashier J.R., Stratman N.C., Mathews W.R., Buhl A.E., Carter D.B., Tomasselli A.G., Parodi L.A., Heinrikson R.L., Gurney M.E. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature. 402:1999;533-537.
298. Yan R., Munzner J.B., Shuck M.E., Bienkowski M.J. BACE2 functions as an alternative alpha-secretase in cells. The Journal of Biological Chemistry. 276:2001;34019-34027.
299. Yang D.S., Tandon A., Chen F., Yu G., Yu H., Arawaka S., Hasegawa H., Duthie M., Schmidt S.D., Ramabhadran T.V., Nixon R.A., Mathews P.M., Gandy S.E., Mount H.T., St. George-Hyslop P.H., Fraser P.E. Mature glycosylation and trafficking of nicastrin modulate its binding to presenilins. The Journal of Biological Chemistry. 277:2002;28135-28142.
300. Yoshiiwa A., Kamino K., Yamamoto H., Kobayashi T., Imagawa M., Nonomura Y., Yoneda H., Sakai T., Nishiwaki Y., Sato N., Rakugi H., Miki T., Ogihara T. Alpha 1-antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers. Annals of Neurology. 42:1997;115-117.
301. Yoshikai S., Sasaki H., Doh-ura K., Furuya H., Sakaki Y. Genomic organization of the human amyloid beta-protein precursor gene. Gene. 87:1990;257-263.
302. Younkin S.G. Amyloid beta vaccination: Reduced plaques and improved cognition. Nature Medicine. 7:2001;18-19.
303. Yu G., Chen F., Levesque G., Nishimura M., Zhang D.M., Levesque L., Rogaeva E., Xu D., Liang Y., Duthie M., St. George-Hyslop P.H., Fraser P.E. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin. The Journal of Biological Chemistry. 273:1998;16470-16475.
304. Yu G., Chen F., Nishimura M., Steiner H., Tandon A., Kawarai T., Arawaka S., Supala A., Song Y.Q., Rogaeva E., Holmes E., Zhang D.M., Milman P., Fraser P., Haass C., St. George-Hyslop P.H. Mutation of conserved aspartates affect maturation of presenilin 1 and presenilin 2 complexes. Acta Neurologica Scandinavica Supplement. 176:2000;6-11.
305. Yu G., Nishimura M., Arawaka S., Levitan D., Zhang L., Tandon A., Song Y.Q., Rogaeva E., Chen F., Kawarai T., Supala A., Levesque L., Yu H., Yang D.S., Holmes E., Milman P., Liang Y., Zhang D.M., Xu D.H., Sato C., Rogaev E., Smith M., Janus C., Zhang Y., Aebersold R., Farrer L.S., Sorbi S., Bruni A., Fraser P., St. George-Hyslop P.H. Nicastrin modulates presenilin-mediated Notch/glp-1 signal transduction and betaAPP processing. Nature. 407:2000;48-54.
306. Zannis V.I., Just P.W., Breslow J.L. Human apolipoprotein E isoprotein subclasses are genetically determined. American Journal of Human Genetics. 33:1981;11-24.
307. Zhang J., Kang D.E., Xia W., Okochi M., Mori H., Selkoe D.J., Koo E.H. Subcellular distribution and turnover of presenilins in transfected cells. The Journal of Biological Chemistry. 273:1998;12436-12442.
308. Zubenko G.S., Hughes H.B., Stiffler J.S., Hurtt M.R., Kaplan B.B. A genome survey for novel Alzheimer disease risk loci: Results at 10-cM resolution. Genomics. 50:1998;121-128.